Nuvation Bio Inc. — Director's Dealing 2024

Sep 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2024-09-03

Reporting Person: Bazemore Robert B (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-03	Stock Option (Right to Buy)	$2.98	A	200801	Acquired	2034-09-02	Class A Common Stock (200801)	Direct

Footnotes

F1: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (September 3, 2024); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.